26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
29 March 2019
Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.
Consultation response to Facing the Facts, Shaping the Future: A draft health and care workforce strategy for England to 2027
26 March 2018
The RCPCH has submitted a response to Health Education England’s consultation Facing the Facts, Shaping the Future: A draft health and care workforce strategy for England to 2027.
26 January 2018
The RCPCH recognises the substantial impact that decisions by the General Medical Council and the High Court have on medical professionals. This case is tragic for all involved, the child, the family, a nurse and a doctor. The case has also engendered anxiety, anger and bewilderment.
5 December 2017
Doctors, and indeed all healthcare staff, are committed to delivering high quality, safe care and avoiding errors. But when errors do occur, as they will on occasion, it is crucial to reflect, understand why the mistake happened and do everything possible to prevent a similar occurrence again.